SC Retrasib SA reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was RON 192.35 million compared to RON 149.07 million a year ago. Net income was RON 0.979151 million compared to net loss of RON 1.24 million a year ago. Basic earnings per share from continuing operations was RON 0.21 compared to basic loss per share from continuing operations of RON 0.265 a year ago.